BECN1 and osteosarcoma: Chemotherapeutic agents, such as cisplatin (DDP), doxorubicin, and methotrexate, have been shown to upregulate Beclin‐1 expression in osteosarcoma cells, whereas Beclin‐1 knockdown suppresses osteosarcoma cell proliferation, metastasis, and invasion [20].